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Abstract
Background: Multipotent neural stem cells (NSCs) have been isolated from neurogenic regions of the adult brain.
Reportedly, these cells can be expanded in vitro under prolonged mitogen stimulation without propensity to transform.
However, the constitutive activation of the cellular machinery required to bypass apoptosis and senescence places these
cells at risk for malignant transformation.
Methodology/Principal Findings: Using serum-free medium supplemented with epidermal growth factor (EGF) and basic
fibroblast growth factor (bFGF), we established clonally derived NS/progenitor cell (NS/PC) cultures from the olfactory bulb
(OB) of five adult patients. The NS/PC cultures obtained from one OB specimen lost growth factor dependence and neuronal
differentiation at early passage. These cells developed glioblastoma tumors upon xenografting in immunosuppressed mice.
The remaining NS/PC cultures were propagated either as floating neurospheres or as adherent monolayers with
mainteinance of growth factor dependence and multipotentiality at late passage. These cells were engrafted onto the CNS
of immunosuppressed rodents. Overall, the grafted NS/PCs homed in the host parenchyma showing ramified morphology
and neuronal marker expression. However, a group of animals transplanted with NS/PCs obtained from an adherent culture
developed fast growing tumors histologically resembling neuroesthesioblastoma. Cytogenetic and molecular analyses
showed that the NS/PC undergo chromosomal changes with repeated in vitro passages under mitogen stimulation, and
that up-regulation of hTERT and NOTCH1 associates with in vivo tumorigenicity.
Conclusions/Significance: Using culturing techniques described in current literature, NS/PCs arise from the OB of adult
patients which in vivo either integrate in the CNS parenchyma showing neuron-like features or initiate tumor formation.
Extensive xenografting studies on each human derived NS cell line appear mandatory before any use of these cells in the
clinical setting.
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Introduction
Due to their ability to self-renew and to differentiate towards the
neuronal phenoype, human adult neural stem cells (NSCs) provide
an attractive tool for transplantation-based therapy of neurode-
generative diseases that avoids the ethical issues raised by the use
of human embryos. However, proliferation and self-renewal
properties make NSCs sensitive targets for malignant transforma-
tion [1]. Some evidence suggests that adult mouse NSCs are quite
resistant to transform even in high-passage cultures under mitogen
stimulation [2]. In contrast, neural precursors from the adult rat
subventricular zone (SVZ) have recently been shown to transform
into tumorigenic cell lines after expansion in vitro [3]. Moreover,
several arguments advise caution before grafting NSCs in patients
that include, a) evidence that glioblastoma may arise de novo from
the oncogenic transformation of NSCs [1,4], b) common
molecular determinants regulating neurogenesis and tumorigenesis
[5–7], and c) generation of glioma-like lesions following growth
factor stimulation of the adult SVZ [8].
The forebrain SVZ and the dentate girus of the hippocampus
are two areas of persistent neurogenesis in the adult brain. These
regions contain dividing cell populations that have been
recognized as NSCs and transit amplifying progenitors (TAPs).
The former are relatively quiescent cells with the capacity of self-
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migratory neuroblasts and oligodendrocyte precursors. In rodents,
TAPs move along the rostral migratory stream to the olfactory
bulb (OB). In humans, a lateral ventricular extension of the
migratory stream to the OB has recently been demonstrated and
NS/progenitor cells (NS/PCs) have successfully been isolated from
the OB, which therefore represents an accessible source of neural
precursors [9–11]. Using xenograft models, we found that human
adult OB-derived NS/PCs are capable of initiating tumor
formation. Although an oncogenic potential has previously been
described in rodent NSCs [3,12–13] and in human adult
mesenchymal stem cells [14], the present work provides the first
demonstration that human adult NS/PCs arising from normal
brain may be tumorigenic in vivo.
Results and Discussion
Tumorigenic human adult NS/PCs arising from an OB
adjacent to meningioma
The OB was harvested from five adult patients who had
undergone surgery for extracerebral benign lesions (Table S1).
Unilateral division of the OB, which is often necessary for surgical
exposure, is well tolerated by the patients because the olfactory
function is preserved. Immunohistochemistry showed that the
human adult OB contains a few hundreds of putative NS/PCs
(Fig. 1). Dissociated OB specimens were cultured in serum-free
medium supplemented with the mitogens EGF and bFGF. Under
these conditions, the OB cells generated primary neurospheres with
latencies that ranged from 6 to 8 weeks (Table S2). An exception
was Case OB3 where primary neurosphere formation was observed
as early as 3 weeks of culturing. Primary neurospheres were
dissociatedintosinglecellsandplatedonecellpermini-well(Fig.1).
Clonal cell cultures were established by dissociation of secondary
neurospheres and passaged up to P30 in mitogens. The ability to
form spheres after serial passaging, the number and diameter of
spheres produced during each passage, and the cloning efficiency
were similar among different cultures (Table S2). Upon removal of
mitogens and serum exposure, the NS/PC cultures obtained from
four of the OB specimens arrested their growth and gave rise to
adherent cells that expressed neuronal, astrocytic, and oligoden-
drocytic markers (Figs. 2A–2B). In contrast, OB3 NS/PC cultures
lost both growth factor dependence and potential to differentiate as
neurons between P4 and P6. Notably, the OB3 patient harbored a
meningioma adjacent to the OB. Losing growth factor dependence
and capacity to differentiate by NSCs may indicate transformation.
On soft agar assay, an in vitro correlate of transformation, the OB3
NS/PCs developed colonies (Fig. S2). Then, we assessed
tumorigenicity in vivo using hetero- and orthotopic xenografts in
immunodeficientmice. Twoto 3 weeks after grafting,NS/PCs from
all OB3 cultures developed subcutaneous tumors with a 88.6
percent take (Fig. 2C and Table 1). Histologically, these tumors
showed glioblastoma features, like perinecrotic pseudo-palisading
and vascular proliferation. Tumorigenicity of OB3 NS/PCs was
demonstrated both at early (P6) and at late passages (P30).
Subcutaneous injection of OB1, OB2, OB4, and OB5 NS/PCs
resulted in amorphous tissue grafts with embedded scarce cells
showing heterogenous morphology and occasional GFAP staining
without neoplastic features (not shown). Intracerebral injection of
OB3 NS/PCs also produced tumors which developed at 63.1
percent of injection sites by 4 to 6 weeks after grafting (Fig. 2D and
Table 1). Histologically, these tumors featured anaplastic astrocy-
toma with predilection for growing into the ventricles. Intracerebral
injection of OB1, OB2, OB4, and OB5-derived NS/PCs did not
result in tumor formation (Table 1).
In principle, taking NS/PCs from patients with pre-existing
tumors nearby the organ where the cells are obtained is
inappropriate. For example, human adult non-tumorigenic NSCs
surrounding low-grade glioma tissue transform in vitro into highly
tumorigenic cancer stem cells [15]. In patient OB3, errant
meningioma cells infiltrating the OB or adhering to its surface
might have overwhelmed the NS/PCs in culture. This hypothesis,
however, seems unlikely because of the following, 1) the phenotype
of meningioma cells (EMA+/GFAP2/NG22/O42) differed
both from that of OB3 NS/PCs (EMA2/GFAP+/NG2+/O4+)
and from OB3-derived tumor xenografts (EMA2/GFAP+/
NG22/O42); 2) sphere generation in serum-free cultures occurs
in glioblastoma, anaplastic astrocytoma, medulloblastoma, and
ependymoma but not in meningioma, and 3) meningioma-derived
NS/PCs are expected to develop xenografts with the histological
appearance of meningioma or sarcoma not of glioblastoma. In
brain pathology, concurrent adjacent meningioma and astrocytic
tumors have been described raising the hypothesis that meningi-
oma-released agents may work as growth factors for the glial cells
of surrounding brain tissue [16]. Thus, the NS/PCs resident in the
OB adjacent to meningioma may undergo chronic pressure for
growth becoming highly sensitive to mitogens in vitro.
Transformation of human adult NS/PCs following
propagation in mitogens and serum
Transplantation technologies of adult human NS/PCs imply
strategies where minimal donor material is highly expanded in vitro
to the adequate cell number before implantation. In general,
NSCs can be expanded either as floating neurospheres in serum-
free medium supplemented with mitogens or as adherent
monolayers in medium containing both mitogens and serum
[17]. Neuronal and oligodendroglial differentiation of adherently
growing NSCs can be enhanced by growth factor withdrawal and
exposure to triiodothyronine (T3) and ascorbic acid [18]. Then,
we propagated GFP-positive OB1, OB2, OB4, and OB5 NS/PCs
between P7 and P10 either under mitogens or under mitogens and
5% serum (Fig. 1). In mitogens and serum, the NS/PCs became
adherent, continued to proliferate, and either maintained an
undifferentiated phenotype or differentiated, mainly as astrocytes
(Fig. 3A). When such adherent serum-stimulated (SS) NS/PCs
were returned to serum-free medium with mitogens, they formed
floating neurospheres within one week maintaining their clonal
efficiency. Upon removal of mitogens and exposure to 1% serum
supplemented with T3 and retinoic acid, the SS-NS/PCs slowered
down their growth and further differentiated towards the
neuronal, astrocytic, and oligodendrocytic lineages (Fig. 3B).
Aberrant coexpression of neuronal and glial markers by the SS-
NS/PCs was not seen.
To examine the behavior of NS/PCs in the CNS environment,
we engrafted GFP-positive NS/PCs, which had been expanded
either as neurospheres or as adherent monolayers, onto the spinal
cord of ciclosporine treated rats or onto the striatum of SCID
mice. Surprisingly, 85.7 percent of the rats engrafted onto the
spinal cord with the clonal SS-OB2a NS/PCs showed progressive
palsy of their hindlimbs by 2 to 4 weeks after grafting. These
animals developed highly infiltrating intramedullary tumors that
histologically were reminiscent of neuroesthesioblastoma, a
malignant neoplasm of the OB that is supposed to arise from an
ancestral neuroblast (Fig. 3C and Table 1). The tumor
xenografts expressed markers for neuronal, astrocyte, and
oligodendrocyte cells. Intracerebral grafting of the SS-OB2a
NS/PCs also resulted in tumor formation with 76.9 percent take
(Fig. 3D and Table 1). Importantly, the clonally-derived OB2a
NS/PCs which had been expanded as neurospheres homed in the
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marker expression without generating any tumor (Figs. 3C–3D).
Similar findings were seen in animals engrafted with OB1, OB4,
and OB5 NS/PCs irrespective the technique used for their
propagation in vitro. Thus, the oncogenic transformation of human
adult NSCs may occur whether a combination of expansion/
selection stimuli, like mitogens and serum, are simultaneously
applied to these cells in vitro. Consistently, mouse embryonic NS
Figure 1. Summary of experimental design. The OB was obtained from adult patients who underwent neurosurgical operations. On
immunohistochemical analysis, the human OB was found to contain about 700 to 1000 cells expressing the NS markers nestin and CD133. The nestin-
expressing cells colocalize glial fibrillary acid protein (GFAP). These cells are located either within the inner plexiform layer close to the lateral olfactory
tract where they show an astrocyte-like morphology, or in the external plexiform layer where they mainly appear as small rounded or unipolar cells. In
the external plexiform layer, a few proliferating cells (n, 200–300) are detected by Ki67 labeling. Dissociated OB specimens were cultured in serum-
free medium supplemented with the mitogens EGF and bFGF. Primary neurospheres were dissociated into single cells and plated one cell per mini-
well. Clonal cell cultures were established by dissociation of secondary neurospheres. Clonal cultures from each OB were passaged up to P30 in
mitogens. NS/PC cultures which lost growth factor dependence and multipotentiality were assessed for tumorigenicity in vivo. At P6, the NS/PCs that
maintained growth factor dependence and multipotentiality were transduced to express GFP. The GFP-positive NS/PCs were expanded either as
neurospheres in serum-free medium supplemented with mitogens or as adherent monolayers in medium containing mitogens and serum and then
engrafted onto the striatum or spinal cord of immunocompromised rodents.
doi:10.1371/journal.pone.0004434.g001
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PLoS ONE | www.plosone.org 3 February 2009 | Volume 4 | Issue 2 | e4434Figure 2. Characterization and grafting of OB-derived NS/PCs cultured as neurospheres. A, Growth curves of NS/PCs (P6) cultured in
serum-free medium supplemented with mitogens (left) and in medium containing 1% serum without mitogens (center). The OB3 cells continue to
proliferate in spite of mitogen removal and serum stimulation. Absorbance test for NS/PC viability (right). B, Immunophenotyping of OB-derived NS/
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expanded with FGF, develop tumors in vivo [1].
Cytological and molecular characteristics of tumorigenic
NS/PCs
Somatic stem cells are thought to possess proficient mechanisms
that allow replicative potential and chromosomal stability.
However, chromosomal rearrangements have been detected in
long-term expanded adult murine NSCs which apparently do not
result in a malignant phenotype [2]. We performed kariotype
analysis on NS/PCs at regular time points and found chromo-
somal rearrangements with repeated passages under mitogen
stimulation (Figs. 4A and S1). Chromosomal changes were found
both in tumorigenic and in non-tumorigenic NS/PCs suggesting
that these cells need additional requirements to achieve tumori-
genicity in vivo. It has been reported that the tumor-like growth
properties of the stem cells associate with changes either in
oncosuppressors or in oncogenes [2,5–6,15]. Then, we set up a
custom real-time RT-PCR array to analyze the expression of 92
mRNAs related with cell proliferation and cancer in tumorigenic
relative to non tumorigenic NS/PCs both under proliferating
culture conditions and under serum-induced differentiation
(Fig. 4B). Relative to the non tumorigenic OB1a and SS-OB1a
NS/PCs, tumorigenic OB3a and SS-OB2a NS/PCs showed
upregulation of genes related to cell proliferation and inhibiting
apoptosis, though solely hTERT and NOTCH1 were overex-
pressed independently from mitogen stimulation. Tumorigenic
OB3a and SS-OB2a NS/PCs did express the hTERT protein,
which was undetectable in non tumorigenic NS/PCs, consistent
with that reported in normal NS cells (Fig. 4C) [19]. Immuno-
fluorescence with anti-NOTCH1 antibody on tumorigenic OB3a
and SS-OB2a NS/PCs demonstrated either increased cytoplasmic
staining or abnormal nuclear staining (Fig. 4D). Following
NOTCH1 blockade with the c-secretase inhibitor X (GSI),
OB3a and SS-OB2a NS/PCs lost their ability to form soft-agar
colonies suggesting a functional role of NOTCH1 in tumorige-
nicity of these cells (Figs. 4C and S2). Although the xenografts
grown after injection of OB3a and SS-OB2a NS/PCs were
histologically reminiscent of different tumors, in both of them
molecular analyses pointed to hTERT and NOTCH1 as critical
pathways. Telomerase is highly expressed in the majority of
human cancers including glioblastoma, where it is believed to
contribute to tumor progression because telomerase-dependent
telomere maintenance provides cells with an extended proliferative
potential [20]. Glioblastoma stem cells, which express telomerase
under proliferating serum-free conditions, transiently lose telome-
rase activity in serum-containing media; however, these cells
regain telomerase at passages coincident with their exponential
growth phase [21]. NOTCH is known to promote the prolifer-
ation of nonneoplastic NSCs and to inhibit their differentiation; it
is also highly activated in embryonal brain tumors, such as
medulloblastoma, where it is required both for maintaining the
stem cell fraction in vitro and for tumor formation in vivo [22]. Up-
regulation of hTERT and NOTCH1 in both tumorigenic OB3a
and SS-OB2a NS/PCs suggests that a common mechanism may
underly the malignant transformation of these cells, and that the
histological differences between the OB3a-derived glioblastoma
and the SS-OB2a-derived neuroesthesioblastoma may reflect
different stages at which the NS/PCs have undergone neoplastic
transformation in culture. In the OB3a-derived glioblastoma, the
tumorigenic hit may have occurred in an astrocytic-committed
precursor cell, whilst in the SS-OB2a-derived neuroesthesioblas-
toma the cell of origin may be a less differentiated NS/PC that has
retained its multipotentiality.
Gene therapy trials using human hematopoietic stem cells after
retroviral transduction have demonstrated a risk of insertional
mutagenesis and oncogenic transformation [23]. However, we do
not believe that that the tumorigenic transformation of the OB-
derived NS/PCs may be a consequence of the use of the lentiviral
vector that integrated the GFP gene into the genome of these cells.
The following arguments do not favour this hypothesis, 1) the OB3
cells, which in vivo gave origin to glioblastoma-like tumors, were
not transduced with lentivirus to express GFP; 2) both the OB2
cells and the SS-OB2 cells were transduced with lentivirus,
however, only the latter cells developed tumor in vivo, whilst the
GFP-positive OB2 cells did not; and 3) the lentivirally transduced
OB1, OB4, and OB5 NS/PCs were not tumorigenic in vivo.
To conclude, human adult NS/PCs cultured under mitogen
stimulation are prone to develop chromosomal rearrangements. In
vivo tumorigenicity is heralded by, 1) short latency in primary
neurosphere formation, 2) persistent growth after removal of
mitogens, 3) loss of serum-induced neuronal differentiation, and 4)
up-regulation of hTERT and NOTCH1. The tumorigenic
transformation of human adult NS/PCs isolated from an OB
adjacent to meningioma raises the possibility that unusual levels of
growth factors in the in situ condition, i.e. prior to ex vivo culture,
may prime tumorigenicity. This indicates that the tumorigenic
potential of the OB3 NS/PCs may be a specific feature of this cell
line and not generalizable. In the case of SS-OB2 NS/PCs,
however, specific culture conditions seem critical to transforma-
tion. Mitogens used simultaneously with factors favouring cell
specification may disrupt the regulatory mechanisms that control
self-renewal of NSCs and differentiation of TAPs. Therefore,
culturing techniques where both proliferation and differentiation
of NS/PCs are simultaneously enhanced should be evaluated
further in future and discouraged if confirmed as linked to in vivo
tumorigenicity.
Materials and Methods
Isolation, Culturing, and Immunophenotyping of NS/PCs
The OB was harvested from adult patients undergoing
craniotomy at the Institute of Neurosurgery, Catholic University,
Rome (Table S1). Informed consent was obtained according to
protocols approved by the Ethical Commettee of the Catholic
University. Immediately after removal, the OBs were dissociated
in Papain 0,1% (Sigma-Aldrich, St. Louis, MO) for 30 minutes at
PCs (P6) cultured in serum-free medium supplemented with mitogens (left) and in medium containing 1% serum without mitogens (right). Double-
positive cells for nestin and GFAP were counted positive for each antigen and also for both antigens (nestin/GFAP). The OB3a cells do not
differentiate towards the neuronal lineage in response to serum stimulation. C, Subcutaneous xenografs of OB3a cells in nude athymic mice. a,
Subcutaneous nodules two weeks after grafting (arrows in a). Histological features of glioblastoma (b, H&E). Expression of astrocytic cell marker GFAP
(c) and negative staining for the neuronal cell marker neurofilament (d). D, Intracerebral tumor xenografts of OB3a cells in SCID mice. Pattern of brain
invasion by OB3a cells one week after grafting into the striatum (a, H&E). Low (b) and high (c and d) magnifications of intraventricular anaplastic
astrocytoma-like tumor by two weeks after grafting (b and c, H&E d, anti-HNA immunoreaction). A, Scale bar 250 mm; b, Scale bar 80 mm; c, Scale bar
50 mm; d, Scale bar 30 mm.
doi:10.1371/journal.pone.0004434.g002
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recombinant EGF (20 ng/ml; PeproTech, Rocky Hill, NJ), human
recombinant bFGF (10 ng/ml; PeproTech), and LIF (20 ng/ml;
Immunological Sciences, Rome, Italy) in DMEM/F12 (1:1)
serum-free medium (Invitrogen, Carlsband, CA) containing L-
glutamine 2 mM, glucose 0.6%, putrescine 9.6 ug/ml, progester-
one 0.025 mg/ml, sodium selenite 5.2 ng/ml, insulin 0.025 mg/
ml, apo-transferrin sodium salt 0.1 mg/ml, sodium bicarbonate
3 mM, Hepes 5 mM, BSA 4 mg/ml, heparin 4 ug/ml [24].
Primary neurospheres were dissociated with Accutase (Invitrogen)
for 4 minutes at 37uC, serially diluted, and plated one cell per
mini-well onto 96-well plates. Mini-wells containg one single cell
were marked after microscopic confirmation and assessed for
secondary neurosphere generation after one week. Secondary
neurospheres were subsequently dissociated, plated at the density
of 10
3 cells/cm
2 in serum-free medium containing EGF and
bFGF, and passaged up to P30. All experiments were done on at
least two clonal cultures from each OB. Between P7 and P10,
parallel cultures were established in which cells were grown as
adherent monolayers in medium containing EGF and bFGF
supplemented with 5% fetal calf serum (Hyclone, Logan, UT). For
cell growth experiments, dissociated cells were plated on Matrigel
at the density of 10
3 cells/cm
2 either in serum-free medium
containing EGF and bFGF or in medium where mitogens were
replaced with 1% serum or in medium containing mitogens and
5% serum (Hyclone). Cells were counted with hemacytometer
every 48 hours. Cell viability was determined colorimetrically by
MTS-assay (Supplementary Methods S1). Differentiation assays
were performed by 14 days after plating on Matrigel coated glass
coverslips in the absence of EGF and bFGF and in the presence of
1% fetal calf serum (Hyclone) supplemented with 39-59-cyclic
adenosine monophosphate (cAMP) 50 mM, all- trans retinoic acid
5 mM (Sigma Aldrich), and triiodothyronine (T3) 30 nM (Sigma
Aldrich). Immunostaining of NS/PCs was performed as described
[15]. We used antibodies against nestin (Chemicon, Temecula,
CA), CD133 (CD133/2; Miltenyi, Bergisch, Germany), GFAP
(Dako, Glostrup, Denmark), b tubulin III (Chemicon), neurofila-
ment RT-97 (Developmental Studies Hybridoma Bank, Iowa
City, IA), MAP2 (Chemicon), NG2 (Chemicon), O4 (Chemicon),
hTERT (Novocastra Laboratories), and NOTCH1 (Chemicon).
Generation of Fluorescent NS/PCs
Enhanced green fluorescent protein (GFP) gene transfer in the
NS/PCs was performed at P6 using a variant of third generation
lentiviral vectors as described [25].
Table 1. Tumor Formation after Grafting of Human Adult OB-
derived NS/PCs in Immunosuppressed Rodents.
Grafted Cells Xenografts (Tumors/Injection points)
Subcutaneous Intracerebral Intramedullary
OB1a P6 0/4
OB1a P8 GFP+ 0/3
OB1a P9 0/2
OB1b P9 0/2
OB1b P9 GFP+ 0/4 0/3
OB1a P10 0/2
OB1a P10 GFP+ 0/3
OB1b P10 GFP+ 0/4
OB1a P18 0/4
SS-OB1a P7 0/4
SS-OB1a P9 GFP+ 0/2 0/2 0/3
SS-OB1b P9 GFP+ 0/2 0/4
OB2a P7 0/4
OB2a P7 GFP+ 0/3
OB2b P7 GFP+ 0/2
OB2b P9 0/4
OB2a P8 GFP+ 0/4 0/4
OB2b P8 GFP+ 0/2 0/5
OB2a P12 0/4
OB2a P10 GFP+ 0/4
OB2b P18 0/4
OB2b P10 GFP+ 0/2
SS-OB2a P7 4/4
SS-OB2a P8 GFP+ 3/5 6/7
SS-OB2b P8 0/4
SS-OB2a P8 GFP+ 4/4
SS-OB2a P10 3/4
SS-OB2a P10 GFP+ 4/4 3/4 12/14
SS-OB2b P10 GFP+ 0/4
OB3a P6 4/4 2/3
OB3b P6 9/10 3/4
OB3a P12 4/4
OB3b P12 2/2
OB3c P12 4/5 3/4
OB3b P18 3/4 2/4
OB3d P18 3/4
OB3a P30 2/2 2/4
OB4a P6 0/4
OB4a P7 GFP+ 0/3
OB4b P6 0/4
OB4a P12 0/4
OB4b P12 0/4
OB4a P10 GFP+ 0/4 0/2
SS-OB4a P8 0/4
SS-OB4b P8 GFP+ 0/4 0/3
SS-OB4a P12 0/4
OB5a P6 0/6
OB5b P6 0/4
Grafted Cells Xenografts (Tumors/Injection points)
Subcutaneous Intracerebral Intramedullary
OB5b P9 0/4
OB5a P8 GFP+ 0/4
OB5b P8 GFP+ 0/3
OB5a P18 0/4
SS-OB5a P8 0/4
SS-OB5a P10 GFP+ 0/4
NS/PCs, neural stem/progenitor cells; OB, olfactory bulb; P, passage in vitro;
GFP, green fluorescent protein; SS, serum stimulated.
doi:10.1371/journal.pone.0004434.t001
Table 1. cont.
Tumorigenic Neural Stem Cells
PLoS ONE | www.plosone.org 6 February 2009 | Volume 4 | Issue 2 | e4434Tumorigenic Neural Stem Cells
PLoS ONE | www.plosone.org 7 February 2009 | Volume 4 | Issue 2 | e4434Grafting of NS/PCs in Immunodeficient Rodents
Studies involving animals were approved by the Ethical
Committee of the Catholic University School of Medicine, Rome.
The NS/PCs were grafted either subcutaneously in nude athymic
mice, or into the brain of severe combined immunodeficient
(SCID) mice, or onto the spinal cord of ciclosporine treated rats
(Supplementary Methods S1). For implantation, the NS/PC
cultures were splitted 24–48 hours prior to transplant and injected
as single cell suspensions. After two to 6-week survival, the animals
were sacrificed with an overdose of barbiturate. Either the
subcutaneous graft or brain or spinal cord was removed and
processed for histology as described [25].
Immunohistochemistry
Immunohistochemistry was performed on deparaffinized sec-
tions using the avidin-biotin-peroxidase complex methods as
Figure 3. Characterization and grafting of serum-stimulated NS/PCs grown as adherent cultures. A, Growth curves (left) and
immunophenotype (right) of NS/PCs (P6) cultured in medium containing mitogens and 5% serum (serum-stimulated, SS-NS/PCs). B, Growth curves
(left), absorbance test (right), and immunophenotype (right) of SS-NS/PCs cultured in 1% serum. C, Grafting of SS-NS/PCs onto the spinal cord of
ciclosporine treated rats. Intramedullary tumor developed four weeks after grafting of SS-OB2a cells (left). Low (a) and high (b) magnification sections
show a neuroesthesioblastoma-like tumor (T) (H&E) expressing both neurofilament (c) and GFAP (d). Tumor cells labeled with GFP (e; green) stain with
the oligodendrocyte cell marker NG2 (red). Homing and differentiation of SS-NS/PCs after grafting onto the spinal cord (left). GFP-labeled SS-OB1a
cells showing neuronal cytology (a). GFP-labeled SS-OB4a cells expressing the neuronal marker neurofilament (GFP green, neurofilament red, merged
signal yellow) (b and c). D, Intracerebral grafts of SS-NS/PCs in SCID mice. Brain tumor developed by two weeks after grafting of GFP-labeled SS-OB2a
cells (a–c; a–b, H&E c, fluorescence microscopy). Grafted SS-OB1a cells do not form tumor by eight weeks after implantation (d–f; d–e, H&E f,
fluorescence microscopy). Left. a, Scale bar 300 mm; b–e, Scale bar 50 mm. Center. a–c, Scale bar 30 mm. Right. a and d, Scale bar 250 mm; b–c and e–f,
Scale bar 70 mm.
doi:10.1371/journal.pone.0004434.g003
Figure 4. Cellular features and molecular profiling of tumorigenic OB-derived NS/PCs. A, Metaphase spread and manually aligned
karyotype of OB3a NS/PCs (P6) showing remarkable chromosomal rearrangements. B, Expression array analysis performed with RNA extracted from
NS/PCs (P7–P8). Gene expression in tumorigenic OB3a and SS-OB2a cells is presented relative to the non tumorigenic OB1a and SS-OB1a cells,
respectively, both under proliferating culture conditions and under serum-induced differentiation. Upregulated genes (2 folds, red), downregulated
genes (2 folds, green), unchanged genes (gray). C, Expression of hTERT protein in OB-derived NS/PCs. Western blot analysis of HUVEC (lane 1), OB1a
(lane 2), OB2a (lane 3), SS-OB2a (lane 4), OB3a (lane 5), and TB10 human glioblastoma (lane 6) cells. Immunohistochemical analysis of hTERT
expression in the human adult OB and OB-derived NS/PCs. The hTERT protein is absent in the adult OB (a) as well as in the non-tumorigenic OB1a (b),
OB2a (c), and SS-OB1a (e) cells. hTERT is strongly expressed in the nuclei of both tumorigenic OB3a (d) and SS-OB2a (f) NS/PCs. Scale bar 40 mm. D,
Immunofluorescence analysis of NOTCH1 expression (left) in OB1a (a), OB3a (b), OB2a (c), and SS-OB2a (d) NS/PCs. NOTCH1 signaling is required for
the formation of colonies in soft agar (right). Exposure to c-secretase inhibior X (GSI) after seeding in soft agar significantly reduced clonigenic
potential of tumorigenic OB3a and SS-OB2a NS/PCs (P,0.0001, Student t-test).
doi:10.1371/journal.pone.0004434.g004
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GFAP (Ylem, Avezzano, Italy), anti-neurofilament (Ylem), anti-
NG2 (Chemicon), anti-CD133/1 (Miltenyi), anti-nestin (Santa
Cruz Biotecnology), anti-human nuclei antigen, (HNA; Chemi-
con), anti-epithelial membrane antigen (EMA; Ylem), anti-Ki67
(Dakocytomation), anti-hTERT (Novocastra Laboratories). En-
dogenous biotin was saturated by biotin blocking kit (Vector). For
antigen retrieval, paraffin sections were microwave-treated in
0.01 M citric acid buffer at pH 6.0 for 10 min. For hTERT
antigen retrieval, paraffin section were microwave-treated in
EDTA buffer at pH 8.0 for 10 min.
Chromosome analysis
NS/PC cultures at P3–P8 were incubated in medium
containing 10 ng/ml colcemid for 18 hours. The cultures were
then lifted and centrifuged. Pellets were osmotically shocked with
0.075 M KCl and fixed with 3:1 methanol:glacial acetic acid.
Standard cytogenetic G bands were performed and a mean of 20
methaphases per cell lines were analyzed.
Macroarray Analysis
We used a 7900HT instrument equipped with SDS2.2 software to
perform a custom real-time RT-PCR array (Microfluidic Card,
Applied Biosystems, CA). Briefly, cells were plated on Matrigel pre-
coated100 mmdishesandprocessedasdescribedabove.Preparation
of total RNA and cDNA was performed using Ribo Pure kit
(Ambion, Austin, TX) and high capacity cDNA Reverse Transcrip-
tase kit (Applied Biosystems), respectively. For data analysis, the
mathematical process for deriving relative quantification values was
used as described by the manufacturer’s guide (Applied Biosystems).
Western Blot
Cell pellets were lysated in a modified RIPA buffer (Tris-HCl
10 mM pH 7.5, NaCl 10 mM, NP-40 0.2%, EGTA 1 mM, EDTA
1 mM, DTT 1 mM and protease inhibitor cocktail; Sigma-Aldrich)
on ice for 5–10 min. Nuclear extracts were resuspended in Urea
buffer (10 M Urea, Tris-HCl 50 mM pH 7.5, DTT 25 mM)
sonicated and normalized using Bradford Assay (Promega Corp).
Protein extracts were analyzed by polyacrylamide gel electropho-
resis and Western blot. Proteins were probed with rabbit polyclonal
anti-TERT (1:1000; Santa Cruz Biotecnology) and monoclonal
anti-b-actin (1:5000; Sigma-Aldrich). As control, HUVEC cells at
passages 4 to 5 (Bio-Wittaker, Walkersville, MD) and TB10
glioblastoma cells were used.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0004434.s001 (0.02 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0004434.s002 (0.02 MB
DOC)
Methods S1 Supplementary Materials and Methods
Found at: doi:10.1371/journal.pone.0004434.s003 (0.04 MB
DOC)
Figure S1 Methaphase spreads and manually aligned karyotypes
on NS/PCs. Both the OB2a NS/PCs, which do not develop
tumor in vivo, and the SS-OB2a NS/PCs, which are tumorigenic
in vivo, show remarkable chromosomal changes at P8–P10,
consisting mainly in deletions. Normal karyotype of OB4a NS/
PCs at P4.
Found at: doi:10.1371/journal.pone.0004434.s004 (9.73 MB TIF)
Figure S2 Soft agar assay (see Supplementary Methods). The
OB2a, SS-OB2a, and OB3a NS/PCs were seeded with a mixture
of Top Agar (0,5%)-proliferation medium on top of the base layer.
The plates were then incubated at 37u in humidified incubator for
3–4 weeks and colonies were counted. Every week fresh medium
mixed with Top-agar was added together with 5 mmol/L c-
secretase inhibitor X (GSI; L-685.458) or DMSO as control.
Three plates for each NSC/PC culture were used.
Found at: doi:10.1371/journal.pone.0004434.s005 (9.58 MB TIF)
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